1. Cheng, Chao-Hung, Kikuchi, Tateki, Chen, Yen-Hui, Chang, Chen, Chen, Yuan-Tsong. 2008. Mutations in the SLC2A10 gene cause arterial abnormalities in mice. In Cardiovascular research, 81, 381-8. doi:10.1093/cvr/cvn319. https://pubmed.ncbi.nlm.nih.gov/19028722/
2. Lin, W H, Chuang, L M, Chen, C H, Cheng, C H, Chen, Y T. 2006. Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population. In Diabetologia, 49, 1214-21. doi:. https://pubmed.ncbi.nlm.nih.gov/16586067/
3. Mohlke, Karen L, Skol, Andrew D, Scott, Laura J, Boehnke, Michael, Collins, Francis S. . Evaluation of SLC2A10 (GLUT10) as a candidate gene for type 2 diabetes and related traits in Finns. In Molecular genetics and metabolism, 85, 323-7. doi:. https://pubmed.ncbi.nlm.nih.gov/15936967/
4. Jiang, Yi-Der, Chang, Yi-Cheng, Chiu, Yen-Feng, Chen, Yuan-Tsong, Chuang, Lee-Ming. 2010. SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10 and PAD in type 2 diabetes. In BMC medical genetics, 11, 126. doi:10.1186/1471-2350-11-126. https://pubmed.ncbi.nlm.nih.gov/20735855/
5. Jian, Lijuan, Wu, Qi, Min, Xinping, Wang, Zhiwei, Hu, Zhipeng. 2023. GLUT10 is a novel immune regulator involved in lung cancer immune cell infiltration and predicts worse survival when transcriptionally downregulated. In Heliyon, 9, e13836. doi:10.1016/j.heliyon.2023.e13836. https://pubmed.ncbi.nlm.nih.gov/36873535/
6. Bento, Jennifer L, Bowden, Donald W, Mychaleckyj, Josyf C, Freedman, Barry I, Segade, Fernando. 2005. Genetic analysis of the GLUT10 glucose transporter (SLC2A10) polymorphisms in Caucasian American type 2 diabetes. In BMC medical genetics, 6, 42. doi:. https://pubmed.ncbi.nlm.nih.gov/16336637/
智鼠故事 
